GZMA and COVID-19: Meanwhile, CTLA4, ENTPD1, TGFB1, LGALS1, EBI3, IL12A, PRF1, GZMA, GZMB, IL2RA, and IL10 were highly expressed in severe COVID-19 patients (Figure 3B).